JCR Pharmaceuticals Co., Ltd.
TSE:4552.T
661 (JPY) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | JCR Pharmaceuticals Co., Ltd. |
Symbool | 4552.T |
Munteenheid | JPY |
Prijs | 661 |
Beurswaarde | 82,953,185,178 |
Dividendpercentage | 3.18% |
52-weken bereik | 466 - 1,339 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Shin Ashida |
Website | https://www.jcrpharm.co.jp |
An error occurred while fetching data.
Over JCR Pharmaceuticals Co., Ltd.
JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (JPY)
Cijfers zijn in miljoenen (JPY)